Member Info for bigbench

This is a company making product for worldwide use... we have a tint Mcap of £30m or there abouts which is ridiculously low for having this product alone... we have other strings to the GDR bow and the SP will re rate pretty soon. Personally i can see us being taken out by a Major pharma in the near future... just my view.

There cant be many more places to move them to dickie!

20% on todays news tells me the markets are asleep while the traders run riot... should be more like 120%.... is it to early to say i wouldn't want to be out over the weekend? :-)

Plenty loading up here TR1's appearing soon..then boom back to 60's

Its been traded the hell out of that's for sure... personally i think we should be sailing past 60p right now but he ho its the game we play here... probably go up 200% next week if i sold out :-0

Tick back up now that's out the way

Mr p.... good to see you're still around chap, the party is just about to get started. Blue soon>

...many having a day off from all the nonsense posted here.... cant blame them.
Come on Art lets have it... the Tea lady has let the cat out the bag. ;-)

Never been away Guy.... now we have movement and it looks like Budd has got his finger out I'm happy to sing the praises here. Start of Dec we were @ 8p and almost lost the will to live... I'm rejuvenated fella ... still underwater but confident not for much longer!

That buyer knows what's coming Jay... few sellers creaming profits fair doos... il top slice @£1

Id say they will be holding for a much bigger payday... this could double or triple bag on a sniff of an approach by bigger player imho

Whatever the potential Global revenue from this may be... i think we can all agree @£32m we are massively undervalued and a sitting duck for big pharma

We encourage relevant stakeholders to participate during the public consultation period to support our pioneering work, and look forward to receiving the final NICE report and recommendations for the world's first rapid point-of-care genetic test used to influence neonatal management in an acute care setting. The timely publication of the NICE guidance is an important outcome that we expect will facilitate further uptake and adoption of the test by NHS England."

This will be landing on clinical directors desks in hospitals all over the world, Big Pharma watching for sure, How this is sub £1 right now baffles me

Also think Budd will be keen to get out further product news while the attention is here with GDR.

GTR it will be way past that in a week or so imho

Imagine the worldwide private sector clinics also wanting this....

Plenty more blue to come next week imho

-- there is currently no test available in the NHS that provides results quickly enough to inform decisions on antibiotic prescribing in emergency care.

-- the long-term savings to the NHS associated with hearing loss and fitting cochlear implants could be substantial.

-- aminoglycoside-induced hearing loss has a major negative impact on the quality of life of children and their families.

This alone makes heart warming reading.. imagine how many big pharma would like their names all over this. i honestly expect this to soar next week.